Jon L. Giacomin, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 47,251 shares at $82.77 ($3.9M) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $3.9M CAH by CEO, Pharmaceutical Segment. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CAH | SELL | 2017-05-15 | $3.4M | — | Filing → |
| CAH | SELL | 2016-08-17 | $3.9M | — | Filing → |